Cargando…

The role of genetic factors in predisposition to squamous cell cancer of the head and neck

© 1999 Cancer Research Campaign

Detalles Bibliográficos
Autores principales:	Jefferies, S, Eeles, R, Goldgar, D, A'Hern, R, Henk, J M, Gore, M, Rhys-Evans, P, Archer, D, Bishop, K, Murkin, A, Solomon, E, Hodgsun, S, O'Connell, M, Hibbert, J, Easton, D, Foulkes, W
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1999
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362666/ https://www.ncbi.nlm.nih.gov/pubmed/10070882 http://dx.doi.org/10.1038/sj.bjc.6690138

Ejemplares similares

No germline mutations in CDKN2A (p16) in patients with squamous cell cancer of the head and neck and second primary tumours
por: Jefferies, S, et al.
Publicado: (2001)

Head and neck sarcomas: prognostic factors and implications for treatment.
por: Eeles, R. A., et al.
Publicado: (1993)

Genetic predisposition to prostate cancer: an update
por: Ni Raghallaigh, Holly, et al.
Publicado: (2021)

HPC2/ELAC2 polymorphisms and prostate cancer risk: analysis by age of onset of disease
por: Meitz, J C, et al.
Publicado: (2002)

How many more breast cancer predisposition genes are there?
por: Easton, Douglas F
Publicado: (1999)

Phase II clinical trial of capecitabine and gemcitabine chemotherapy in patients with metastatic renal carcinoma
por: Waters, J S, et al.
Publicado: (2004)

Randomized phase II trial of BCDT [carmustine (BCNU), cisplatin, dacarbazine (DTIC) and tamoxifen] with or without interferon alpha (IFN-alpha) and interleukin (IL-2) in patients with metastatic melanoma.
por: Johnston, S. R., et al.
Publicado: (1998)

Platinum-Taxol non-cross resistance in epithelial ovarian cancer.
por: Gore, M. E., et al.
Publicado: (1995)

Gefitinib (ZD1839, Iressa™) as palliative treatment in recurrent or metastatic head and neck cancer
por: Kirby, A M, et al.
Publicado: (2006)

Chromosomal radiosensitivity in head and neck cancer patients: evidence for genetic predisposition?
por: De Ruyck, K, et al.
Publicado: (2008)

Genetic predisposition for femoral neck stress fractures in military conscripts
por: Korvala, Johanna, et al.
Publicado: (2010)

Leukopenia predicts outcome in haemato-oncological patients requiring intensive care
por: Margarson, MP, et al.
Publicado: (2001)

A prognostic index that predicts outcome following palliative whole brain radiotherapy for patients with metastatic malignant melanoma
por: Morris, S L, et al.
Publicado: (2004)

Sensitivity to radiation-induced chromosome damage may be a marker of genetic predisposition in young head and neck cancer patients
por: Papworth, R, et al.
Publicado: (2001)

Genetic predisposition to lung cancer.
por: Law, M. R.
Publicado: (1990)

BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients
por: Kote-Jarai, Z, et al.
Publicado: (2011)

BCL10 is rarely mutated in human prostate carcinoma, small-cell lung cancer, head and neck tumours, renal carcinoma and sarcomas
por: Gill, S, et al.
Publicado: (1999)

Characterization of genetic predisposition to molecular subtypes of breast cancer in Brazilian patients
por: Paixão, Daniele, et al.
Publicado: (2022)

Does chemotherapy improve survival in advanced breast cancer? A statistical overview.
por: A'Hern, R. P., et al.
Publicado: (1988)

Germline BRCA1 mutations increase prostate cancer risk
por: Leongamornlert, D, et al.
Publicado: (2012)

Pancreatic cancer as a sentinel for hereditary cancer predisposition
por: Young, Erin L., et al.
Publicado: (2018)

Non-coding RNAs underlie genetic predisposition to breast cancer
por: Moradi Marjaneh, Mahdi, et al.
Publicado: (2020)

Phase I study of intra-arterial interleukin-2 in squamous cell carcinoma of the head and neck.
por: Gore, M. E., et al.
Publicado: (1992)

Hereditary Predispositions to Myelodysplastic Syndrome
por: Bannon, Sarah A., et al.
Publicado: (2016)

Employing multiple synchronous outcome samples per subject to improve study efficiency
por: A’Hern, Roger P.
Publicado: (2021)

Debrisoquine metabolism and genetic predisposition to lung cancer.
por: Law, M. R., et al.
Publicado: (1989)

DNA polymorphisms of several genes and predisposition to breast cancer
por: Zaletayev, D, et al.
Publicado: (2005)

Is There a Predisposition Gene for Ewing's Sarcoma?
por: Randall, R. L., et al.
Publicado: (2010)

A phase II feasibility study of carboplatin followed by sequential weekly paclitaxel and gemcitabine as first-line treatment for ovarian cancer
por: Harries, M, et al.
Publicado: (2004)

Identification of new breast cancer predisposition genes via whole exome sequencing
por: Southey, MC, et al.
Publicado: (2012)

Genetic Predisposition to Hepatocellular Carcinoma
por: Pascale, Rosa M., et al.
Publicado: (2022)

Infection and Predisposition
Publicado: (1901)

Predisposition and Environment
por: Mills, G. Alden
Publicado: (1901)

Chemotherapy and survival in advanced breast cancer: the inclusion of doxorubicin in Cooper type regimens.
por: A'Hern, R. P., et al.
Publicado: (1993)

Childhood T-cell lymphoblastic lymphoma--does early resolution of mediastinal mass predict for final outcome? The United Kingdom Children's Cancer Study Group (UKCCSG).
por: Shepherd, S. F., et al.
Publicado: (1995)

Genetic Predisposition to Clonal Hematopoiesis
por: Quiros, Pedro M., et al.
Publicado: (2023)

Chromosomal radiosensitivity as a marker of predisposition to common cancers?
por: Baria, K, et al.
Publicado: (2001)

Investigating the association of rs2910164 with cancer predisposition in an Irish cohort
por: McVeigh, T P, et al.
Publicado: (2017)

Surveillance following orchidectomy for stage I testicular seminoma.
por: Horwich, A., et al.
Publicado: (1992)

Analysis of survival following treatment of tumour-induced hypercalcaemia with intravenous pamidronate (APD).
por: Ling, P. J., et al.
Publicado: (1995)

Cannot write session to /tmp/vufind_sessions/sess_rrs01098rmggl3b0264rlgdkkr